Guadeloupe vs Slovenia: Prostate cancer death rate in men
Guadeloupe
21.8 deaths per 100,000 people
in 2016
Slovenia
20.97 deaths per 100,000 people
in 2023
Guadeloupe rank
18th
Slovenia rank
19th
Prostate cancer death rate in men over time
- Guadeloupe
- Slovenia
How they compare
Guadeloupe currently reports 21.8 deaths per 100,000 people against 20.97 deaths per 100,000 people in Slovenia, a difference of 0.83 deaths per 100,000 people.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was Guadeloupe ahead.
Guadeloupe ranks 18th and Slovenia ranks 19th of 111 countries.
Guadeloupe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guadeloupe | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.43 deaths per 100,000 people | 24.15 deaths per 100,000 people | 10.28 deaths per 100,000 people | Guadeloupe |
| 2010s | 25.96 deaths per 100,000 people | 21.37 deaths per 100,000 people | 4.59 deaths per 100,000 people | Guadeloupe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prostate cancer death rate in men, Guadeloupe or Slovenia?
- Guadeloupe, at 21.8 deaths per 100,000 people against 20.97 deaths per 100,000 people in Slovenia as of 2016.
- What is the difference in prostate cancer death rate in men between Guadeloupe and Slovenia?
- 0.83 deaths per 100,000 people, with Guadeloupe ahead.
- How many years of comparable data are there for Guadeloupe and Slovenia?
- 17 years are reported by both, from 2000 to 2016.
- How do Guadeloupe and Slovenia rank globally for prostate cancer death rate in men?
- Guadeloupe ranks 18th and Slovenia ranks 19th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Prostate cancer death rate in men. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from prostate cancer in males in those aged all ages per 100,000 people.